FIRE1 has announced that the first US patients have been successfully implanted with its FIRE1 system for remote heart failure monitoring in an early feasibility study (EFS).
The study will assess FIRE1’s novel solution to improve outcomes for heart failure patients. The first patient was implanted at Austin Heart (Austin, Texas), where Kunjan Bhatt leads the study as principal investigator and Thomas McMinn performed the implants.
“We are delighted to announce the first implants in the USA of this new, transformative technology for patients with chronic heart failure,” said Bhatt. “The procedures were very straightforward, and the patients tolerated the procedure well without any complications. We are excited to use the unique insights we will get from this device to improve patient care. On behalf of Austin Heart, the Heart Hospital of Austin, and St David’s Healthcare, we are honoured to launch research of this technology in the USA.”
“This device may offer a completely new way of measuring chronic heart failure,” said Nir Uriel (New York-Presbyterian, New York, USA), National Principal Investigator for the study. “The data gathered outside of the USA has been promising, and we look forward to studying its use in the USA.”
FIRE1 CEO and president, Conor Hanley, said: “We have made great clinical progress in Europe and I am proud to announce the milestone of first cases in the USA, the largest healthcare market in the world. I want to express my gratitude to all the patients who continue to put their faith in us and their care teams who are working tirelessly to bring this important technology to market. The FIRE1 team is committed to its mission of helping millions of patients living with heart failure to get their normal lives back, and today is an important step forward on this journey.”